Actionable Intelligence and Forward-Looking Analysis

The Deal covers corporate transactions, dealmakers and their advisers to help readers identify opportunities and build their businesses. Whether you need a daily source of up-to-the-minute intelligence or a comprehensive dealmaking database, we’re your solution.

Our Focus Areas

Industries We Serve

See All

Upcoming Events

Jan
20
ESG

ESG Roundtable Dublin

Environmental, social and governance (ESG) issues are increasingly finding their way onto the agendas of the world’s most influential investors. Our panel of experts will explore the ESG initiatives being discussed in the boardroom, and how the world’s largest influential investors and shareholder activist funds are capitalizing on this trend.
Feb
26
Corporate Governance

Corporate Governance Europe

Join senior journalists from The Deal for an exclusive conference which will examine the current state of shareholder activism, outline best practices and provide vital guidance around the new age of activism in Europe.
Mar
16
ESG

ESG Roundtable Miami

Environmental, social and governance (ESG) issues are increasingly finding their way onto the agendas of the world’s most influential investors. As a result, the largest companies across the globe are under pressure to properly assess and respond to ESG risks and opportunities. Those companies that are most transparent about their ESG policies and act as first movers in this growing arena are gaining favor with index fund managers. Those that do not, have found themselves in the crosshairs of prominent activist investors. Our panel of experts will explore the ESG initiatives being discussed in the boardroom, and how the world’s largest influential investors and shareholder activist funds are capitalizing on this trend.
Apr
22
Corporate Governance

Corporate Governance Japan

Corporate Governance Japan 2020 explores the barriers for activists operating in Japan. Leading investors and corporate executives will examine the types of governance initiatives, assessments, engagement programs and communication strategies companies should institute in readiness for when an activist comes calling.

News From The Deal

Mergers & Acquisitions

Merck Expands Oncology Pipeline With ArQule

By Armie Margaret Lee
|
Published: December 9th, 2019
The biopharmaceutical giant is paying a 107% premium for the target, which focuses on therapies for treating cancer and rare diseases.
Mergers & Acquisitions

Drinks With The Deal: Chris Varelas

By David Marcus
|
Published: December 6th, 2019
The former Citi tech investment banker and author of 'How Money Became Dangerous' talks with The Deal’s David Marcus about working at Disneyland in the 1980s, being a tech banker after the dot-com crash and investing in influencers.